Nutrition Food Company Investment Opportunity in Athens, Greece
Company manufacturing supplements and multi-vitamin substances seek investment.
This transaction has concluded.
Premium Plan
| Established | 20-30 year(s) |
| Employees | 10 - 50 |
| Legal Entity | Private Limited Company |
| Reported Sales | USD 1 - 2 million |
| Run Rate Sales | USD 1.4 million |
| EBITDA Margin | 20 % |
| Industries | Nutrition Food |
| Locations | Athens |
| Local Time | 3:13 AM Europe / Athens |
| Listed By | Business Owner / Director |
| Status | Active |
Partial Stake Sale
USD
1.05 million
for
40.0%
stake
(Native Currency: EUR 900,000)
Reason: Need funds to expand the company.
Valuation is based on patent and niche market potential.
Valuation is based on patent and niche market potential.
Includes physical assets worth
USD
234 thousand
Interested to connect with advisors
Documents
Domain-Verification.pdf
(213.0 KB)
Investment Requirements
(37.5 KB)
Financials
(57.7 KB)
Business Plan Synopsis
(1.0 MB)
Business Overview
- We outsource the production of the products. We are mainly into trading of the products.
- In our database, we have approx 29,000 customers (clinic, retail, wholesale, doctors, and other health professionals).
- We sell in Greece and export to Cyprus but we have patients that need our products and services in many countries such as USA and Australia although small numbers.
- We own the medical services i. e. diagnostic tools, and therapeutic protocols but we outsource the manufacture of the products and we own the proprietary brands for trading.
- We do not require many employees since we outsource the manufacturing.
- Valuation based on patents, unique medical innovation and market niche.
- There are 2 companies one is medical and the other is involved in trading, outsourcing its label supplement manufacturing and also trading other brands.
- 40% stake will be provided in both of these companies.
- In our database, we have approx 29,000 customers (clinic, retail, wholesale, doctors, and other health professionals).
- We sell in Greece and export to Cyprus but we have patients that need our products and services in many countries such as USA and Australia although small numbers.
- We own the medical services i. e. diagnostic tools, and therapeutic protocols but we outsource the manufacture of the products and we own the proprietary brands for trading.
- We do not require many employees since we outsource the manufacturing.
- Valuation based on patents, unique medical innovation and market niche.
- There are 2 companies one is medical and the other is involved in trading, outsourcing its label supplement manufacturing and also trading other brands.
- 40% stake will be provided in both of these companies.
Products & Services Overview
Manufacturer of supplements, multivitamins, pro-biotics, antioxidants, etc.
Assets Overview
Tangible assets include cars, computers, and stock.
Facilities Overview
The facility is located in the center of the city on 5 story glass building on a 450 square meter area.
Capitalization Overview
- The 2 companies are funded completely by private funds and its existing profits.- There is one shareholder who holds the 100% of both companies.
- The companies have no debts.
Recent Activity
-
Earlier than 15 daysDirector, London, Financial Consultant connected with the Business
-
Earlier than 15 daysManaging Partner, Financial Consultancy, Nashville, Corporate Investor / Buyer connected with the Business
-
Earlier than 15 daysBusiness Development Manager, Food Processing, Thessaloniki, Corporate Investor / Buyer connected with the Business
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct. Note that SMERGERS is not liable for any loss, damage, costs, claims and expenses whatsoever arising from transacting with any other user from the website. The final responsibility of conducting a thorough due diligence and taking the transaction forward lies with the users. Please read best practices on SMERGERS.
